
Sign up to save your podcasts
Or


One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150
By Michael Putman4.9
114114 ratings
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination for "more B cell depletion than rituximab" strategies.
Article: https://www.nejm.org/doi/full/10.1056/NEJMc2407150

503 Listeners

296 Listeners

129 Listeners

3,368 Listeners

1,147 Listeners

119 Listeners

194 Listeners

519 Listeners

67 Listeners

4 Listeners

375 Listeners

183 Listeners

186 Listeners

19 Listeners

6 Listeners